This opportunity uses the R01 (Clinical Trial Optional) Research Project Grant funding mechanism.
The purpose of this funding opportunity announcement (FOA) is to stimulate clinical research that harnesses the wealth of advances in the fields of genomics and other omics (e.g. metabolomics, microbiomics, proteomics, transcriptomics, epigenomics etc.) to incorporate these advances into translatable, personalized biobehavioral interventions for improved health outcomes.
Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Submission Requirements & Due Date
- Applications must be submitted for internal review by 29 January 2020
- Please email email@example.com if you are considering applying for this scheme.
- See also: Submitting an Application to Research Services for Review